# Incremental Hemodialysis: The TwoPlus Trial

Study · id `cardio:ct-nct05828823` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05828823](<https://clinicaltrials.gov/study/NCT05828823>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05828823

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

## Technical summary

Registry record NCT05828823. Randomized; no masking; primary purpose treatment. Start 2024-02-26 (actual); primary completion 2030-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT05828823, source copy `cardio:ctgov-nct05828823-2026-08-06`, retrieved 2026-10-26)
- Started: 2024-02-26 (actual) (ClinicalTrials.gov record NCT05828823, source copy `cardio:ctgov-nct05828823-2026-08-06`, retrieved 2026-10-26)
- Primary completion: 2030-07 (anticipated) (ClinicalTrials.gov record NCT05828823, source copy `cardio:ctgov-nct05828823-2026-08-06`, retrieved 2026-10-26)
- Completion: 2031-01 (anticipated) (ClinicalTrials.gov record NCT05828823, source copy `cardio:ctgov-nct05828823-2026-08-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05828823, source copy `cardio:ctgov-nct05828823-2026-08-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05828823-2026-08-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Incremental Hemodialysis: The TwoPlus Trial
- Condition: End-Stage Kidney Disease
- Intervention (Device): Hemodialysis twice weekly
- Intervention (Other): Hemodialysis thrice weekly
- Lead sponsor: Wake Forest University Health Sciences
- Lead sponsor class: OTHER
- Collaborator: Patient-Centered Outcomes Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Wake Forest University Health Sciences (`cardio:wake-forest-health-sciences`)
- Registry lists this organization as a collaborator: Patient-Centered Outcomes Research Institute (`cardio:org-patient-centered-outcomes-research-institute`)

## Provenance

Content hash: f4fc2ae30a76ff2740a3c4384e7d0a1a133d9e0a31228fb81da1eef95d7cc615
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
